INTRODUCTION
1Mutations are early events in carcinogenesis and defective DNA repair is a risk factor for many cancer [1] . The maintenance of genome integrity is very important for the survival of all organisms and DNA repair systems play a crucial role. The reduction in DNA repair capacity likely leads to birth defects, cancer and reduced lifespan [2] . At least three syndromes are associated with inborn defects in NER: Xeroderma pigmentosum(XP), Cockayne syndrome(CS) and trichothiodystrophy (TTD), all characterized by exquisite sun sensitivity. The prototype repair disorder, xeroderma1 pigmentosum  XPB and XPD helicases of the repair and transcription factor IIH (TFIIH), allowing damage verification by the XPA protein. Single-strand binding protein RPA prevents reannealing and dual incisions in the damaged strand are caused by the ERCC1-XPF and XPG endonucleases, excising the damage as part of a piece of 25 to 30 bases. The single-strand gap is filled by the replication machinery, and the final nick sealed by DNA ligase [3, 7] .
XPA (xeroderma pigmentosum, complementation group A) locates at 9q22.3 and encodes a zinc finger protein with affinity for various DNA damages involved in DNA excision repair [8] . XPA has many interactions with other NER components, such as the single-strand binding complex replication protein A (RPA), the TFIIH complex and the ERCC1/XPF endonucleases. XPA may orchestrate the repair machinery around the DNA lesion when XPC/HHR23B with or without the help of TFIIH has locally opened the helix [6] . XPA G23A (reference SNP ID: rs1800975) is an important polymorphism in XPA that is a A to G (or G to A) transition at fourth nucleotide upstream from the ATG start codon in 5'-UTR.
XPC (xeroderma pigmentosum, complementation group C) is located at 19q13.3. It encodes a component of the NER pathway and plays an important role in the early steps of GG-NER. In GG-NER, XPC and HR23B form XPC-HR23B complex to recognize DNA damage and initiate to combine with other NER factors to accomplish the NER [5, 9] . The important polymorphisms of XPC are XPC C499T, XPC A939C and XPC PAT. XPC C499T (XPC Ala499Val; reference SNP ID: rs2228000) is a C-to-T transition in exon 8, resulting in the change Ala499-> Val. XPCA939C(XPC Lys939Gln: reference SNP ID: rs2228001) is a A-to-C transition in exon 15, leading to the change Lys939->Gln. Poly-AT(XPC PAT) consisting of an insertion of 83 bases of A and T[poly(AT)] and a 5 base deletion within intron9 [10] . As XPC A939C was found to be in strong linkage disequilibrium with the XPC PAT [10, 11] . We just recruited XPC A939C in our meta-analysis in the two polymorphisms. XPD (ERCC2, excision repair cross-complementing rodent repair deficiency, complementation group 2) is located at 19q13.3. XPD protein involves in transcription-coupled nucleotide excision repair and is an integral member of the basal transcription factor BTF2/TFIIH complex. The gene product has ATP-dependent DNA helicase activity and belongs to the RAD3/XPD subfamily of helicases. Thepolymorphisms of XPD are XPD A751C, XPD G312A and XPD C156A.XPD A751C (XPD Lys751Gln; reference SNP ID: rs13181) is an A-to-C transition in exon23, resulting in the change Lys751-> Gln.
XPD G312A (XPD Asp312Asn; reference SNP ID: rs1799793) is a G-to-A transition in exon10, resulting in the change Asp312-> Asn. XPD C156A (XPD Arg156Arg; reference SNP ID: 238406) is a C-to-A transition in exon6 and is a silent polymorphism.
In recent years, an increasing body of epidemiologic studies on lung cancers demonstrated that the potential role of polymorphisms of genes in NER pathway. However, the results showed controversial. Herein, we perform a meta-analysis to evaluate the associations between the polymorphisms of XPA, XPC and XPD genes in NER pathway and lung cancer risk.
MATERIALS AND METHODS

Search Strategy and Identification of Eligibility of Studies
To examine the association of XPA, XPC, XPD polymorphisms with lung cancer, we conducted a computerized literature search of Pubmed database and EMBASE(last search updated in October 2009) using the keywords and subject terms "XPA", "XPC", "XPD/ ERCC2", "lung" "cancer/neoplasm/tumor/carcinoma", "polymorphism" in published references. The studies included in our meta-analysis all met the following criteria: The study use an unrelated case-control design and had genotype frequency available.
Data Extraction
Data were collected on the genotype of XPA G23A(rs1800975), XPC C499T (rs2228000), XPC A939C (rs2228001), XPD A751C(rs13181), XPD G312A(rs1799793) and XPD C156A(rs238406), We collected following data from each studies: first author's surname, year of publication, ethnicity, country of origin, source of controls, genotyping method, number of case and control groups, minor allele frequency of controls. The following categories for ethnicity in our meta-analysis were listed: Caucasian; Asian; African Americans; Mexican American; Latinos; Mixed. The details of these studies in the meta-analysis were in Table 1 . 
Meta Analysis
The summary odds ratio (OR) and 95% confidence internal (95%CI) were used to estimate the association between the six polymorphisms of NER genes and lung cancer risk. For each polymorphism, we used individuals with the homozygous common genotype as the reference group and calculated OR for those with the heterozygous genotype and homozygous rare genotype. We also used individuals with the heterozygous genotype as the reference group and calculated OR for individuals with the homozygous rare genotype. The association between rare allele of gene polymorphisms and lung cancer risks were evaluated using dominant and recessive genetic models. Moreover, studies were divided into subgroups according to the ethnicity of samples. Heterogeneity among combined studies was assessed with the chi-square based Q-test [37] . P<0.01 was considered significant difference. I 2 was also used to evaluate for heterogeneity. The closer to zero I 2 is more likely no difference. Less than 0.25 is considered mild, between 0.25 and 0.5 was considered moderate and greater than 0.75 was considered high degree of heterogeneity [38] . When no heterogeneity existed, fixed effect model with Mantel-Haenszel method was used to combine data. When heterogeneity existed, random effect model with Inverse Variance method was used. The pool OR was analyzed for statistical significance by the Z test. The same analysis method was applied to the subgroups divided according to ethnicity. Potential publication bias was evaluated by using funnel plots and Egger's test [39] . Hardy-Weinberg equilibrium (HWE) for genotype frequencies was tested by Chi-Square test. Data mentioned above were performed using STATA version 11.0 (STATA Corporation) and Review Manager 5.0(Oxford, England) software. All P values were two-sided.
RESULTS
The Studies and Meta-analysis Databases
A total of 31 publications retrieved from Pubmed and EMBASE met our inclusion criteria. Among it, six publications were excluded because of reported publication [40] , and same population that had been reported [41] [42] [43] [44] [45] . Thus, 25 publications were included in our meta-analysis, including 10 publications in Asian [17] [18] [19] [20] [21] [23] [24] [25] [26] [27] , 6 publications in the United States [15, 22, 28, 29, 34, 35] and 9 publications in European countries [12] [13] [14] 16, [30] [31] [32] [33] 36] . Three publications recruited subjects of different racial descents. David et al [28] focused their recruitment on African Americans and Caucasian subjects. Chang et al [22] provided data on subjects of Latinos and African Americans. Wu [15] provided data on subjects of Caucasians, African Americans and Mexican Americans. The different races in the publications were considered as separate studies. Spitz et al [35] provided genotyping data of American population and which was defined as "mixed" ethnic. One study [22] used Illumina's GoldenGate genotyping platform and the others used PCR-based methods to genotype. In five studies, the distribution of genotypes frequencies in control group was not in Hardy-Weinberg equilibrium [15, 16, 21, 22, 27] . All of them were published in English. Among the 25 publications, 6 publications (8 studies) investigated XPA G23A [12] [13] [14] [15] [16] [17] . 4 studies studied XPC C499T [18] [19] [20] [21] . 6 publications (7 studies) focused on XPC A939C [14, [18] [19] [20] [21] [22] . 19 publications(21 studies) tested XPD A751C [12] [13] [14] 16, [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] . 16 publications (17 studies) examined XPD G312A [12] [13] [14] 16, 21, 22, 24, 25, 27, [30] [31] [32] [33] [34] [35] [36] , and 3 publications (4 studies) analyzed XPD C156A [21, 22, 27] . The distribution of the alleles and genotypes among cases and controls are shown in Table 2 .
XPA and Lung Cancer Risk
XPA, coding for zinc-finger DNA binding protein and plays a central role at an early stage in the NER pathway for it plays in DNA lesion recognition and its interaction with other NER repair proteins. Variations of XPA gene probably affect protein function and NER pathway [46] . XPA G23A was found in the 5' non-coding region of the XPA gene, a A-to-G substitution in the nucleotide -4 from ATG start codon [47] . 5' UTR might be essential for gene expression through transcriptional and post-transcriptional control mechanisms [48] . Polymorphisms in this area proximal to the start codon could have implications for the binding of the 40S ribosomal subunit and as a result influence protein levels in the cell [49] .
The pooled analysis for XPA G23A included 2206 cases and 2502 controls. In the meta-analysis, the 23A allele frequency was varied from 0.334 to 0.361 in Caucasians [12] [13] [14] 16] except for a outlier 0.446 [15] , which was reported in a study that showed a evident HWE deviation. And it was 0.478 in Asians [17] , 0.299 in African Americans and 0.394 in Mexican-American [15] . In all controls of the recruited studies, XPA 23G allele was more common than 23A allele. We assumed G allele was wild allele and a allele as variant allele. Overall, significant between-study heterogeneity in 8 studies was found when we analysis the association between A allele and lung cancer risk, compared with G allele. Random-effect model was used to combine data. No significant association was found between the 23A allele and lung cancer risk in all subjects (P=0. 29 [15] in Caucasians, the distribution of genotypes frequencies in control group was not in Hardy-Weinberg equilibrium. We excluded this study and performed meta-analysis once again. However, no significant association was found between XPA G23A and lung cancer risk in total population and in Caucasians.
Pool analysis was done in the 8 studies using individuals with the AA genotype as the reference group and calculated summary OR for those with the AG or GG genotype. Moreover, we evaluated the relationship between GG genotype and lung cancer risk in comparing with the combination of AA and AG genotype. In total population, no heterogeneity existed in the 8 studies, under fix-effect model, comparing with AA, carriers with AG or GG both reduced the risk of lung cancer (P=0.002, OR=0.76, 95%CI:0.65-0.91, P heterogeneity =0.43; P=0.02, OR=0.82, 95%CI: 0.69-0.97, P heterogeneity =0.29). In Caucasian, the protective effect was observed in AG vs AA (P=0.005, OR=0.76, 95%CI: 0.63-0.92, P heterogeneity =0.65). However, excluding the study of [15] , which showed a evident HWE deviation, no association was found between XPA G23A and lung cancer risk in total population and in Caucasians.
XPC Polymorphisms and Lung Cancer Risk
XPC binds to HR23B forming XPC-HR23B complex and play a crucial role in the recruitment of TFIIH to damaged DNA and initiate and combine with other NER factors in global genome repair [5, 9, 50] . XPC also plays an unexpected and multifaceted role in cell protection from oxidative DNA damage [51] . 100% of mice with deleted XPC develop spontaneous lung tumors. XPC allelic loss may be an etiological factor in lung tumorigenesis in humans [52] . XPC A939C and XPC C499T were two key polymorphisms in XPC. XPC A939C is a A-to-C transition in exon 15, resulting in the change Lys939->Gln. XPC C499T is a C-to-T transition in exon8, resulting in the change Ala499-> Val. XPC C499T were found in LD with XPC A939C and XPC PAT [20, 21, 53] .
The association studies between XPC A939C, C499T and lung cancer risk were mostly from Asians. Most of studies [14, 18, 21, 22] reported there have no association between the two polymorphisms with the lung cancer risk except for two studies in Asians.Hu et al [19] reported 939C and 499T variant genotype respectively and combined to elevate lung cancer risk and more pronounced among smokers. Lee et al [20] revealed 939C were associated with a decreased risk of small cell carcinoma (adOR=0.58, 95%CI:0.35-0.97). No significant interaction between the XPC Lys939Gln polymorphism and smoking and intake of fruit/vegetables was found [14, 20] .
XPC C499T and Lung Cancer Risk
The pooled analysis for XPC C499T included 1862 cases and 1854 controls. The 499T allele frequency was varied from 0.284 to 0.332 in Asian [18] [19] [20] [21] . All of the 4 studies of XPC C499T recruited in the meta-analysis were from Asian population. Except for the CTvsCC contrast and the CT+TTvsCC contrast (dominate genetic model), no significant heterogeneity was observed between the 4 studies in any genetic model. Using random-effect model on the CTvsCC contrast and CT+TTvsCC contrast and using fix-effect model on the rest genetic model, no evidence of an association between XPC C499T and lung cancer risk was found. To identify sources of heterogeneity further, we exclude each study in turn and found after excluding the study of Hu [19] , the heterogeneity between studies was not significant any more. Meanwhile, there were also no significant association between XPC C499T and lung cancer risk.
XPC A939C and Lung Cancer Risk
There are 2650 cases and 3211 controls included in the pooled analysis for XPCA939C. In the meta-analysis, the 939C allele frequency was varied from 0.326 to 0.394 in Asians [18] [19] [20] [21] . And it was 0.368 in Caucasians [14] , 0.307 in African Americans and 0.29 in Latinos [22] .
In total population, no significant heterogeneity was observed between the 7 studies and the fix-effect . In Asians, no heterogeneity was observed among the 6 studies. However, after excluded the study of Shen [21] , no significant association was found between XPC A939C and lung cancer risk.
In Caucasians [14] , the XPC A939C CC genotype was associated with a non-significant 41% higher IRR for lung cancer than the XPC A939C AA wild type. In African Americans and Latinos, no remarkable association was found between XPC A939C and lung cancer risk [22] .
XPD A751C and Lung Cancer Risk
There are 7385 cases and 9453 controls included in the pooled analysis for XPD A751C. In the meta-analysis, the751C allele frequency was varied from 0.04 to 0.111 in Asians [17, 21, 24, 25, 27] except for a outlier 0.403 [23] . The 751C allele frequency was varied from 0.273 to 0.407 in Caucasians [12] [13] [14] 16, [28] [29] [30] [31] [32] [33] [34] . It was varied from 0.225 to 0.25 in African Americans [22, 28] , 0.219 in Latinos [22] and 0.333 in the mixed ethnicity in the United States [35] .
Overall, no heterogeneity was observed between the 21 studies and the fix-effect model was used to combine data. =0.95 ) and dominate genetic model (P=0.004, OR=1.14, 95%CI: 1.04-1.24, P heterogeneity =0.89). In Asians, except for the dominate genetic model and C vs. A, no heterogeneity was found in any genetic model. Using the random-effect model on the dominate genetic model and C vs. A and using fix-effect model on the rest genetic model, no significant association between XPD A751C and lung cancer risk was found in Asians. Further identifying sources of heterogeneity in Asians, we found the heterogeneity decreased after excluding the study of Chen et al [23] and even disappeared after excluding the study of Shen et al [21] . In African Americans, no heterogeneity was found between the studies. Under fix-effect model, no association between XPD A751C and lung cancer risk was found.
In the 21 recruited studies, in a study of Zienolddiny et al [16] in Caucasians, the distribution of genotypes frequencies in control group was not in HWE. We excluded the study and performed meta-analysis once again. No heterogeneity was found between 20 studies in total population and in Caucasians. Under fix-effect model, the association of CC genotype and C allele with elevation of lung cancer risk was also observed in the recessive genetic model ( 
XPD G312A and Lung Cancer Risk
A total of 6434 cases and 8202 controls were included in the pooled analysis of XPD G312A. In the meta-analysis, the 312A allele frequency was varied from 0.057 to 0.065 in 3 studies of Asians [21, 24, 25] . Except for a very low figure 0.006, which from a study of Yin et al [27] . The distribution of genotypes in the study was not in HWE. The 312A allele frequency was varied from 0.296 to 0.436 in Caucasians [12] [13] [14] 16, [30] [31] [32] [33] [34] 36] . It was 0.126 in African Americans [22] , 0.197 in Latinos [22] .
In total population, no heterogeneity was observed between the 17 studies and the fix-effect model was used to combine data, 
XPD C156A and Lung Cancer Risk
A total of 716 cases and 905 controls were included in the pooled analysis of XPD C156A. In the meta-analysis, the 156A allele frequency was varied from 0.441 to 0.459, 0.136 and 0.412 in Asian [21, 27] , in African Americans [22] and in Latinos [22] respectively.
Overall, no heterogeneity was observed between the 4 studies when analysis all the genetic models. Using fix-effect model to combine data. In total population, carriers with the AA genotype significantly increased the risk of lung cancer in the genetic recessive model (P=0.04, OR=1.36, 95%CI: 1.02-1.81, P heterogeneity =0.71) and homozygote comparison (P=0.04, OR=1.42, 95%CI: 1.02-1.97, P heterogeneity =0.58). In the subgroup analysis by ethnicity, in Asian, except for the analysis of dominate genetic model and AC vs. CC contrast, no heterogeneity was observed. The random-effect model was used to combine data in the two genetic models and the fix-effect model to the rest genetic model. No association was found between XPD C156A and lung cancer risk.
Publication Bias
We performed the funnel plot and Egger's test to evaluate publication bias of XPA G23A, XPC A939C, XPD A751C, XPD G312A. As limited data in XPC C499T and XPD C156A, we didn't evaluate their publication bias with the same method. No significant publication bias was found in these polymorphisms 
DISCUSSION
Nucleotide excision repair is a highly versatile DNA damage repair pathway by which the vast majority of DNA damage can be removed through incisions on both sides of the lesion. In humans, the NER system is an important defense mechanism against two major carcinogens, sunlight and cigarette smoke [54] . It has two branches: global genome repair, which probes the genome for strand distortions and transcription-coupled repair, which removes distorting lesions that block elongating RNA polymerases [3] . NER involves more than 30 proteins [55] . We analysis the association between 6 common polymorphisms of 3 NER genes and lung cancer risk in the meta-analysis. A total of 25 publications (61 studies) were included. Following polymorphisms were examined: XPA G23A, XPC C499T, XPC A939C, XPD A751C, XPD G312A and XPD C156A .We found XPA G23AAA genotype elevated lung cancer risk in total population and in Caucasians. AG or GG genotype decreased lung cancer risk in total population, AG genotype decreased lung cancer risk in Caucasians. However, after excluding a study in Caucasians, which was not in HWE [15] .
The result showed no association between XPA G23A and lung cancer risk in total population and in Caucasians. XPC A939C CC genotype elevated lung cancer risk in total population and in Asians. However, after excluding a study in Asian [21] , which was not in HWE. CC genotype elevated lung cancer risk was verified in total population but not in Asians. All studies recruited in the meta-analysis are about Asians and no association was found between XPC C499T and lung cancer risk in Asians. In the case of XPD A751 C, 751C allele and CC genotype both elevated lung cancer risk in total population and in Caucasians. The result was verified even after excluding a study in Caucasians [16] , which was not in HWE. No association was found between XPD A751C and lung cancer risk in Asians and African Americans. XPD G312A AA genotype elevated risk of lung cancer in total population, in Asians and Caucasians. The result was verified even after excluding a study in Asians [27] , which was not in HWE. XPD C156A AA genotype increased the risk of lung cancer in total population but had no association with lung cancer risk in Asians. However, after excluding a study in Latinos [22] , which showed a evident HWE deviation, the C156A was found have no association with lung cancer risk in total population. XPC A939C was in linkage disequilibrium with XPC PAT and IVS11-5C->A(IVS11-5C->A was a SNP discovered in the XPC intron11 splice acceptor) [20, 56] . Khan et al found the three polymorphisms are consistent with a haplotype of PAT-/intron 11C/exon15 A in -60% of the donors and PAT+/intron11A/exon15C in-40%of the donors. The A allele of intron11 splice acceptor, which has a lower information content than the C allele and is associated with a higher frequency of deletion of exon12. This exon 12 deleted XPC mRNA isoform has reduced DNA repair activity. Thus this might increase cancer susceptibility [56] .Utilizing post-UV host cell reactivation to assess DNA repair capacity of polymorphic alleles and found similar DNA repair with XPC939A and XPC939C [10] . XPC939C variant could affect the irradiation-specific DNA repair rates [57] . A recent study [53] revealed based on the mutagen-challenged comet assay, compared with their wild allele, the variant allele C of A939C decreased DRC and the variant allele T of C499T elevated DRC. Most of the functional studies revealed the polymorphisms of XPD modified the DNA repair capacity. Duell et al [58] reported XPD Lys751Gln was unrelated to sister chromatid exchange frequencies or DNA adduct level by a less than 80 subjects study. Some studies revealed the variant 751Gln and 312Asn genotypes were associated with less optimal DRC to repair BPDE or UV-induced DNA damage compared with wild-type alleles in the host cell reactivation assay [35, 59, 60] and were associated with higher DNA adducts [30, [61] [62] [63] . They were also reported to have significantly association with increased chromosome aberrations (CAs) following exposure to UV light, but not to X-rays, which suggested these variant genotypes appear to be defective in nucleotide excision repair [29, 64] . On the other hand, Lunn et al [65] . Compared XPD genotype at codon312 and 751 with DNA repair proficiency in 31 women and found the Lys/Lys751 genotype was associated with sub-optimal repair of DNA damage induced by X-irradiation. The Asp312Asn polymorphism did not appear to affect DNA repair proficiency. Vodicka et al [57] revealed that 751A allele(AA and AC) genotypes elevated the levels of chromosomal aberrations (CAs) and may increase the risk of SSB formation in peripheral lymphocytes.
The combination or interaction analysis between gene and gene in NER pathway showed The polymorphisms in XPC and XPD increased the risk of developing lung cancer and the association was particularly important for ever smokers and patients with adenocarcinomas [31] . Popanda [13] found a >5-fold increased risk for SCC (squamous cell carcinoma) in individuals with three variant NER alleles[XPA(-4A/A) and the XPD 312Asn/Asn and 751Gln/Gln] indicating that combinations of variant alleles within a specific pathway can affect the risk for SCC much stronger than the single variants.
Populations in different genetic background might account for the different association with lung cancer risk. In our meta-analysis, the prevalence of the variant allele in XPD A751C and G312A varies markedly among Caucasians and Asians. The 751C allele frequency was varied from 0.273 to 0.407 in Caucasians.The751C allele frequency was varied from 0.04 to 0.111 in Asians except for a evident outlier 0.403, which was reported by Chen et al [23] . The distribution of genotype frequency in the study varies markedly from the other Asian studies and it is probably some genotyping error in it. After excluding this study, however, the result of meta-analysis were not affected significantly (data not shown). The 312A allele frequency was varied from0.296 to 0.436 in Caucasians and varied from 0.057 to 0.065 in Asians except for a very low figure of 0.006, which from a study of Yin et al [27] . The 312A allele frequency in the study showed an evident HWE deviation. XPD G312A was observed to be in linkage disequilibrium with A751C [25, 30, 31, [34] [35] [36] 42] . Moreover, studies in Caucasians found G312A is in linkage disequilibria with both C156A and A751C [66] , C156A and A751C are tightly association [67] . However, the haplotype structure and frequency between populations were significant different in European, African and Asian individuals. In both the African and Asian populations, C156A was not significantly linked to A751C [68] . In our meta-analysis, the 156A allele frequency was varied from0.441 to 0.459 in Asian and very different from African Americans (0.136). No relative reports in Caucasians were recruited.
A number of association studies aimed to identify genetic variant that influence susceptibility to lung cancer. But the reports were not always consistently reproducible. The inconsistency may be due to too small samples, not population-based and among different ethnicity background, and so on. Meta-analysis, a statistical tool for combining results across studies, is becoming popular as a method for resolving discrepancies in genetic association studies [69] . It not only increases the power to detect an association but also helps make sense of conflicting results. It plays an important role in assessing that replication and in providing an estimate of the size of the genetic effect [70] . In our meta-analysis, total 25 publications were recruited and extracted data to pool analysis, which greatly increase the statistical power. We evaluated the role of NER genetic polymorphisms just in lung cancer rather than in all site cancer. It is because of that when examining the role of polymorphisms in DNA repair genes on cancer susceptibility, it is important to consider the importance of 'gene-environment' interaction, which are crucial to characterize low-penetrance genes [71] . Carcinogenic mechanism may differ by different tumor sites. A genotype have elevation association with cancer in this site might have reduction association with cancer in that site [71] . Recently, there were 3 meta-analysis of the association between XPC polymorphisms(Lys939Gln; Ala499Val) and cancer risk [71] [72] [73] . They all observed 939Gln homozygote significantly elevate the risk of lung cancer in all subjects. Two meta-analysis [74, 75] of the association between XPD polymorphisms (Lys751Gln, Asp312Asn) and cancer or lung cancer risk were published in past two years. Kiyohara [75] found 751Gln/Gln genotype was associated with increasing risk of lung cancer and did not found 312Asn/ Asn genotype was significant associated with lung cancer risk in all subject. But another meta-analysis [74] reported 751Gln/ Gln and 312Asn/Asn were both associated with increasing risk of lung cancer in all subjects. Kiyohara et al [75] found a protective effect of the XPA 23G/G genotype in all subjects. For meta-analysis of genetic association studies, there was no consensus on whether to recruit the study that was not in Hardy-Weinberg equilibrium. Zhang et al [72] and Wang et al [74] excluded studies that was not in Hardy-Weinberg equilibrium. Qiu et al [73] and Kiyohara et al [75] recruited all relative studies regardless of study that was in Hardy-Weinberg equilibrium or not. Attia et al [76] suggested that sensitivity analysis should be performed, pooling with and without studies not in HWE, to test the robustness of the results.
In our meta-analysis, we focused on the association between polymorphisms of NER genes and lung cancer risk. We recruited more updated publications and polymorphisms of NER, as well as gave more detailed results on the base of ethnicity. Moreover, we estimated the deviations from Hardy-Weinberg equilibrium in the controls for each studies and make meta-analysis before and after excluding the study that was not in HWE. Thus, we assessed the sensitivity of the results by meta-analysis. We found that excluding the studies were not in HWE, the result of meta-analysis in XPD A751C and XPD G312A were not change. XPD A751C. C allele and CC genotype elevated lung cancer risk was also verified in total population and in Caucasians. No association was found between XPD A751C and lung cancer risk in Asians and African Americans. XPD G312A, AA genotype elevated risk of lung cancer in total population in Asians and Caucasians. However, the results of following polymorphisms of NER showed some difference after excluding the studies were not in HWE. For XPCA939C, CC genotype elevated lung cancer risk in total population but not in Asian population. C156A was no association with lung cancer risk in total population and in Asian population. It is noteworthy that after excluding the study was not in HWE, the result showed no association between XPAG23A and lung cancer risk in total population and in Caucasians, which is very different with the result when we recruited all studies. There is some limitation in our meta-analysis. First, some studies have suffered from a relatively small sample size or in some subgroup of ethnicity, the number of studies available were limited, which result in lacking enough statistical power to detect the true association between the polymorphism and lung cancer. Second, the available data from the individual studies are not detailed enough and we can not perform the pooled analysis to examine the combined effect of multiply polymorphisms or environmental factors. So did the linkage disequilibrium and haplotype analysis. Third, subjects were briefly divided in smoker and non-smoker may not reflect the true association between the polymorphism and lung cancer risk. In the meanwhile, Smoking statue defined different in different studies. We can not perform the pooled analysis to evaluate the interaction between polymorphisms and smoke statue. The last, the number of studies in XPA G23A and XPD C156A are limited and we did not perform the funnel plot and Egger's test to evaluate their publication bias.
In conclusion, the meta-analysis indicates that the polymorphisms of NER genes XPC and XPD may play a role in the evaluating the risk of lung cancer. XPD A751C C allele and CC genotype elevate lung cancer risk in total and Caucasians population. No significant association was found between XPD A751C and lung cancer risk in Asians and African Americans. XPD G312A AA genotype increases risk of lung cancer in the total, Asians and Caucasians populations. XPC A939C CC genotype increased lung cancer risk in total population and but not in Asians. No significant association between XPA G23A, XPC C499T, XPD C156A and lung cancer risk was found. Lung cancer is a complex disease and influenced by gene-gene, gene-environment interaction. Multiply genes and environment factors might interact and contribute to the occurrence of lung cancer. Future study needs to be done to confirm the relationship among multiply polymorphisms of candidate gene, environment factors and lung cancer risk.

